Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 82Leukemia, Myeloid, Acute 63Leukemia, Myelomonocytic, Chronic 31Leukemia 21Myeloproliferative Disorders 15Primary Myelofibrosis 9Thrombocythemia, Essential 7Polycythemia Vera 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Blast Crisis 7Myelodysplastic-Myeloproliferative Diseases 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Recurrence 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Biphenotypic, Acute 4Anemia, Refractory, with Excess of Blasts 4Anemia, Refractory 4Leukemia, Monocytic, Acute 3Congenital Abnormalities 3Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Thrombocytopenia 1Systemic Mastocytosis With an Associated Hematologic Neoplasm 1Preleukemia 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1

Interventions

AP 1903 reagent 3ON 01910 2thymoglobulin 1fludarabine phosphate 1fludarabine 1epacadostat 1cedazuridine 1Therapeutics 1Sertraline 1Peripheral Blood Stem Cell Transplantation 1Interleukin-8 1IDO-1 inhibitor LY3381916 1HuMax-IL8 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Exercise 1Decitabine 1DNA 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1Bone Marrow Transplantation 1Biopsy 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cytopenia × Decitabine × Myeloid × Clear all
NCT05148234 2025-09-30

BMS-986253 in Myelodysplastic Syndromes

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
2 enrolled 11 charts
Classical hematologyMyeloid

Cytopenia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡